
Ken Young
Managing Partner
Get their honest, personalized take on your startup.
Sign in to pitch Ken →At a glance
- Full Name
- Ken Young
- Title
- Managing Partner and Chief Operating Officer; Chair, CVC Credit
- Firm
- CVC
- Firm Type
- Global private markets manager across private equity, secondaries, credit and infrastructure
- Investment Stage
- Private equity, private credit, liquid credit and CLO strategies; no verified evidence found that he is an angel or seed-stage investor
- Target Company Profile
- Fundamentally sound, well-managed businesses; for credit, sub-investment-grade corporate borrowers and sponsor-backed financings
- Sector Focus
- Broad multi-sector platform; CVC lists technology, healthcare, sports, media and entertainment, financial and business services, consumer, and education among relevant strategy areas
- Geographic Focus
- Global platform, with credit activity focused on Europe and North America
- Location
- London, United Kingdom
Background
Ken Young is Managing Partner and Chief Operating Officer at CVC, a global private markets manager. He joined CVC in September 2008 and has held multiple leadership roles across the organization. His remit has included capital markets, investor relations / client and product solutions, fund administration, business development and global capital raising.
Young was appointed Chair of CVC Credit in 2020 and became COO of CVC in 2023, according to The Marque. CVC’s own 2023 CLO Equity III announcement identifies him as “Managing Partner, Chief Operating Officer of CVC and Chair of CVC Credit.”
Before CVC, Young was an Executive Director at J.P. Morgan from September 2006 to September 2008, working in leveraged finance and originating / underwriting European leveraged finance transactions. Earlier, he spent six years at CIBC, also as an Executive Director.
Young began his career in law. He trained at Dickson Minto from 1996 to 1998, then joined Allen & Overy as an associate banking lawyer focused on European leveraged finance from 1998 to 2000. He holds an LL.B and Diploma in Legal Practice from the University of Edinburgh.
Investment Thesis & Focus
- CVC’s firm-wide approach centers on investing in “fundamentally sound, well-managed businesses” and using its global network to source opportunities and create value.
- Young’s public investment focus is institutional private markets rather than angel investing. His role is tied to CVC’s global capital raising, business development, capital markets and CVC Credit.
- CVC Credit invests across sub-investment-grade corporate credit markets in Europe and North America through liquid credit and private credit strategies.
- CVC Credit emphasizes downside protection, active risk management, local-market investment teams and access to the broader CVC platform.
- Young has described CVC Credit as “central to everything we’re building across CVC” and highlighted the CVC Network as a sourcing and assessment advantage.
- CVC Credit states that the “basis of every good investment decision” is access to information, supported by proprietary credit analysis and a database tracking more than 4,000 credits.
- The most relevant founder profile is a mature, sponsor-backed or institutionally financed company, not a seed startup.
Notable Investments
- Immedica Pharma: CVC Credit provided debt facilities in 2025 to support KKR and Impilo’s joint acquisition of the Swedish rare-disease pharmaceutical company.
- APRIL Group: CVC Credit committed senior facilities in 2023 to support KKR’s acquisition of the French insurance broker-distributor.
- idealista: CVC’s fourth European Direct Lending fund backed Cinven’s acquisition of the Spanish online real-estate marketplace.
- smartTrade: CVC’s fourth European Direct Lending fund supported the company’s acquisition and growth strategy.
- Innovative Beauty Group: CVC’s fourth European Direct Lending fund acted as sole lender for the acquisition.
- Alpha FMC: CVC’s fourth European Direct Lending fund supported Bridgepoint’s delisting of Alpha FMC from AIM.
- Curium: CVC Credit cited a €315 million PIK underwriting for Curium as part of its private credit expansion in 2020.
- CVC CLO Equity III: Closed in 2023 at its $800 million hard cap, intended to support more than $10 billion of CVC-managed CLO issuance.
- CVC European Direct Lending IV: Closed in 2025 with €10.4 billion to deploy across European direct lending opportunities.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.